Abstract. Clear cell renal cell carcinoma (ccRCC) metastasis may result from epithelial-to-mesenchymal transition and mesenchymal stem cells that contribute to the development of the primary tumor. In this study, it was demonstrated that microRNA-21 (miR-21) acts as an oncogenic driver of ccRCC. ccRCC spheres were isolated and it was shown that they exhibited cancer stem cell-like properties, including the formation of self-renewing spheres. Spheres showed increased expression of stem cell-related transcription factors and epithelial-mesenchymal transition (EMT) markers. In addition, secondary sphere formation capacity was assessed after miR-21 transfection. miR-21 accelerated the formation of ccRCC spheres, which shared molecular characteristics with the spontaneous ccRCC spheres. It was demonstrated that miR-21 overexpression facilitates ccRCC sphere formation. Thus, a single miRNA may have an impact on the formation of highly tumorigenic cancer spheres in kidney cancer.
Introduction
Incidence of renal carcinoma is the third highest of all urinary system tumors, accounting for ~3% of adult malignancies worldwide (1) . Kidney cancer represents one of the 10 most common types of human cancer and is often resistant to chemotherapy. In addition, the morbidity and mortality of this type of cancer continues to increase (2) . Approximately 70% of patients with renal cancer fall into the subgroup of clear cell renal cell carcinoma (ccRCC) (3) and a quarter of these patients have metastatic disease at initial diagnosis.
The short noncoding microRNAs (19-25 nucleotides) are an abundant class of small RNA that are important in gene regulation (4) . MicroRNAs suppress protein expression by predominantly binding with imperfect complementarity to the 3' untranslated region of mRNAs to either repress translation or induce mRNA degradation (5) . In a study using normal and ccRCC tumor tissues, miR-21 expression was increased in renal tumor tissue samples compared with adjacent nontumorous tissue samples (6) . Although numerous mRNAs have been identified to be the targets of miR-21, few have been demonstrated to exhibit a specific role in tumorigenesis particularly in renal cancer.
The ʻcancer stem cellʼ (CSC) model suggests that a small subset of cancer cells possess stem cell properties and are crucial in tumor initiation, tumor metastasis and resistance to anticancer therapy (7) . CSC populations have been identified and characterized in a number of solid tumors, including melanoma, breast, brain, lung, colon, prostate, pancreatic and colorectal cancers (8) . The characteristic features of CSCs include self-renewing properties, high tumorigenicity and the ability to differentiate into the cell types of the tumor of origin (9) . Epithelial-mesenchymal transition (EMT) is important in inducing CSC formation in the epithelial cells of breast (10) , colorectal (11) , gastric (12) and prostate (13) cancers. Moreover, EMT was associated with increased expression of stem cell-related transcription factors and increased tumorigenic ability (14) . The CSC model and EMT concepts have been integrated into a model which proposes that stationary CSCs are activated rendering them able to migrate to, and undergo EMT at the metastatic site (15) .
In the present study, CSC-like cells with side population (SP) cell phenotype were isolated from human ccRCC cell lines to examine whether miRNAs contribute to the acquisition and maintenance of CSC characteristics in ccRCC. It was demonstrated that SP cells were highly clonogenic in vitro. These spheres showed increased expression of stem cell-related transcription factors and mesenchymal markers suggesting that EMT is a contributor to the gain of CSC features. Finally, it was identified that miR-21 overexpression results in the formation of cancer spheres. in PBS for 3 h. The membrane was then reprobed with polyclonal goat anti-mouse (ab6789; 1:5,000) and goat anti-rabbit (ab97051; 1:10,000) secondary antibodies (Abcam) conjugated with horseradish peroxidase for 40 min at room temperature. Blots were processed using an enhanced chemiluminescence kit (Santa Cruz Biotechnology Inc.) and exposed to film (Kodak, Rochester, NY, USA).
Materials and methods

Patients
Cell culture and transfection assay. The 786-O and UOK-117 ccRCC cells were obtained from RIKEN BioResource Center (Ibaraki, Japan). Cells were cultured in RPMI-1640 medium (Gibco; Thermo Fisher Scientific, Inc.), supplemented with 10% fetal bovine serum (FBS; Atlanta Biologicals, Lawrenceville, GA, USA), 100 U/ml penicillin and 100 µg/ml streptomycin at 37˚C with 5% CO 2 . HK-2 cells were purchased from the American Type Culture Collection (Manassas, VA, USA). Cells were cultured as a monolayer in Keratinocyte Serum Free Medium (K-SFM) supplemented with 0.05 mg/ml bovine pituitary extract, 5 ng/ml human recombinant epidermal growth factor (EGF; Invitrogen; Thermo Fisher Scientific, Inc.) and 10% fetal bovine serum, 50 mg/ml penicillin and 50 mg/ml streptomycin (all from Invitrogen; Thermo Fisher Scientific, Inc.). The miRNA inhibitors 2'-O-methyl antisense oligonucleotide targeting miR-21 (anti-miR-21), the miRNA inhibitor negative control (anti-miR-C), the pre-miR-21, and the mimic positive control were purchased from Shanghai GenePharma Co., Ltd. (Shanghai, China).
For 6 ) were then stained with Annexin V-fluorescein isothiocyanate and propidium iodide labeling solution (BD Biosciences, Franklin Lakes, NJ, USA), and then analyzed using a flow cytometer (Beckman Coulter, Brea, CA, USA) and an Annexin V/Dead Cell Apoptosis kit for flow cytometry (V13241, Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's instructions.
Transwell assay. The migration and invasion of ccRCC cells were determined using a Transwell assay. Membranes (8 mm filter) were embedded with collagen (Millipore). UOK-117 or 786-O cells (2.5x10 stain from the membrane was eluted in DMSO according to the manufacturer's instructions. The absorbance of the eluted stain was measured with a spectrophotometer at 590 nm. This measurement was used arbitrarily as an indicator of the number of cells that had migrated or invaded (19) .
Wound scratch assay. Equal numbers of cells were plated in each well of twelve-well culture plates. After the cells reached 70-80% confluence, a line was scratched in the middle of the well using a pipette tip to create a wound. Images of the denuded area were captured using an inverted microscope (Motic Incoporation) just after the denudation (time, 0 h). Following incubation for another 48 h, images were again captured. For quantitation, the area of the wound was measured and normalized to vehicle-treated controls. To investigate the effects of miR-21 on migration of UOK-117 and 786-O cells, the cells were transfected with pre-miR-21 or anti-miR-21 and their respective negative controls for 24 h, after which the wound was created and the images were captured at 0 h (20) .
CSC sorting. CSC sorting and culture were performed as previously described (21) (22) (23) . Briefly, under standard conditions, ccRCC cells were grown in RPMI-1640 (glucose 4.5 g/l) supplemented with L-glutamine, sodium pyruvate, 10% FBS and penicillin/streptomycin, in a humidified atmosphere at 37˚C under 5% CO 2 . Under sphere culture conditions, parental cell lines or the floating spheres obtained from transfections were plated in serum-free defined media (SFDM), which consisted of low-glucose (1 g/l) RPMI-1640 supplemented with L-Glutamine, sodium pyruvate, penicillin/streptomycin (Wisent Bio Products, Saint-Jean-Baptiste, QC, Canada), 20 ng/ml basic fibroblast growth factor (FGF), 20 ng/ml EGF, and B27 (Invitrogen; Thermo Fisher Scientific, Inc.) using 24-well ultra-low attachment plates (Corning Inc., Tewksbury, MA, USA). Spheres were dissociated with trypsin every 5-7 days and split to a 1:3 ratio. For the sphere formation assay, 500 cells/well were seeded in an ultra-low attachment 96-well plate (Corning Inc.) in 100 µl SFDM/ well. SFDM (25 µl/well) was added every day for 3 weeks. Wells were photographed at 4x magnification (Nikon Eclipse TS100; Nikon, Tokyo, Japan). Sphere number was determined by ImageJ program, version 1.37 (National Institutes of Health, Bethesda, MA, USA).
Statistical analysis. Data are presented as the mean ± standard deviation. Comparisons were made using one-way analysis of variance, and Student's t-test was used to analyze the differences between two experimental groups. Statistical analyses were performed using the SPSS version 17.0 software (SPSS, Inc., Chicago, IL, USA).. All experiments were repeated at least three times, and representative experiments are shown. P<0.05 was considered to indicate a statistically significant difference.
Results
Expression of miR-21 is upregulated in ccRCC.
The expression of miR-21 mRNA was examined in UOK-117 and 786-O ccRCC cells and normal HK-2 cells by RT-qPCR. miR-21 mRNA expression in ccRCC cells was significantly higher compared with that in the normal HK-2 cells (Fig. 1A) .
Furthermore, the relative expression of miR-21 was compared between cancer tissues and adjacent tissues, and it was demonstrated that cancer tissues had higher miR-21 expression (Fig. 1B) .
miR-21 promotes ccRCC cell proliferation and decreases apoptosis.
To investigate the functional role of the upregulation (Fig. 1C and D) , and it was clearly shown that the two types of ccRCC cells displayed a decreased apoptotic rate compared with the controls (Fig. 2) (24) .
Effects of miR-21 overexpression on cell migration and invasion.
Next, the role of miR-21 in regulating migration of ccRCC cells was determined using a Transwell chamber assay and wound scratch assay. Transfection with pre-miR-21 showed marked invasion, and anti-miR-21 blocked this invasion (Figs. 3 and 4) . Quantification of these results showed significant changes in the ability to invade. Together these results demonstrated that miR-21 facilitates invasion of the two types of ccRCC cells (19) . E-cadherin). The levels of all the proteins were upregulated in UOK-117 and 786-O cells, compared with controls, respectively (Fig. 5) . These data suggested that miR-21 can promote EMT of UOK-117 and 786-O cells.
Isolation of cancer spheres with stem cell properties from ccRCC cell lines. UOK-117 and 786-O cells were cultured in SFDM which was shown to support the formation of CSC spheres. Under these conditions, sphere formation was observed from the two ccRCC cell lines (Fig. 6A) . Spheres could be propagated in three dimensional (3D) cultures in an ultra-low adherent dish for several passages. The ability of cell lines to form spheres in vitro depends on the presence of a self-renewing cell population. To assess the clonogenic potential of these sphere-forming cells, a single cell suspension prepared from UOK-117 and 786-O spheres and the parental cell lines was plated in SFDM. Large spheres were observed in 4-6 weeks. The sphere-derived cells typically formed >2 fold more spheres than the parental cell lines.
The role of miR-21 in cancer initiation and progression remains controversial. To determine the possible effect of miR-21 on ccRCC cancer sphere formation, ccRCC cell lines were transiently transfected with either pre-miR-21 or anti-miR-21. Transfection of UOK-117 and 786-O cells with pre-miR-21 led to rapid formation of 3D spheres (Fig. 6B ), which were morphologically indistinguishable from the spheres obtained in SFDM (Fig. 6A) . To confirm the ability of miR-21 to facilitate self-renewal, the clonogenic capacity of UOK-117 and 786-O cells was quantified upon miR-21 or treatment with transfection agent. miR-21 resulted in 1.9-fold increase in the number of colonies in the UOK-117 cell line and 1.5-fold increase in the number of colonies in the 786-O cell line compared with the transfection agent control (Fig. 6C and D ).
Discussion
The current data investigated the expression of the recently identified tumor promoter miR-21, and demonstrated that miR-21 enhances the formation and/or stabilization of highly tumorigenic ccRCC spheres.
miR-21 was one of the first oncomiRs to be identified, and it has since been confirmed to be upregulated in numerous (25) . In ccRCC, increased expression of miR-21 is associated with increased proliferation and invasion, and decreased apoptosis. Numerous studies have identified multiple miRNAs with potential prognostic or diagnostic use (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) . Our data suggest that miR-21 was shown to be an independent prognostic factor for patients with ccRCC without metastasis at the time of diagnosis.
In recent years, research on CSCs in solid tumors have shown important findings. Baker et al (37) demonstrated that CSCs were a unique cell subpopulation, and a driving force for tumor growth in brain cancer, colon cancer and skin cancer. In this study, SP cells were isolated from human ccRCC cell lines to determine the biological properties of this cell population. A clone formation efficiency of SP cells higher than that of non-SP (NSP) cells was observed. These results provide direct evidence for the high tumorigenicity of SP cells. Self-renewal and multi-lineage differentiation capacities are hallmarks of stem cells. CSCs are considered to be able to undergo an asymmetrical self-renewing cell division, dividing into one stem cell and one progenitor cell, which could generate a variety of more differentiated functional cells that comprise the whole tumor society (38) .
In conclusion, the data support the hypothesis that reduction of miR-21 expression may be able to to directly inhibit the proliferation of ccRCC cells. In addition, ccRCC spheres were isolated from two ccRCC cell lines and exhibited CSC-like properties including the formation of self-renewing spheres in serum-free defined media, high clonogenicity and increased expression of stem cell-specific transcription factors. In addition, it was also demonstrated that miR-21 may contribute to the acquisition of stem cell properties in metastatic ccRCC cell line models. The transfection of miR-21, enhanced the expression of EMT maker proteins, which was coupled with the presence of stem cell-like properties. The results of the present study suggested that miR-21 may be a promising new target for patients with ccRCC, which remains to be investigated in animal models.
